[1]
S. Anjum, A. Bhatti, F. Qadir, U. Ashraf, and P. John, “RANKL Signaling Pathway: A Potential Target for Antiresorptive Therapy in Rheumatoid Arthritis”, NJNS, vol. 3, no. 1, pp. 35–52, Feb. 2021.